Riskpilot← Back to searchSign inGet full accessEndorfin Dopamin AB
ABActiveOrg 5591439152Oktavgatan 5Sports and recreation education · NACE 8551Est. 20181 employees
Revenue 2024
SEK 163K
-43% vs 2023
EBITDA margin
-43.8%
-199% vs 2023
Equity ratio
89.9%
Financial strength
Net profit 2024
SEK -71K
-225% vs 2023
| Revenue | SEK 163K | -43% |
| EBITDA | SEK -71K | -199% |
| Net profit | SEK -71K | -225% |
| Total assets | SEK 94K | -54% |
| Equity | SEK 85K | -46% |
| Employees | 1 | — |
Legal name
Endorfin Dopamin AB
Org number
5591439152
Legal form
Aktiebolag
NACE code
8551 · Sports and recreation education
Founded
5 januari 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva träning, friskvård, utbildning och rådgivning till individer och organisationer. Bolaget skall bedriva konsultverksamhet inom friskvård och därtill förenlig verksamhet. Bolaget skall bedriva kulturell, artistisk verksamhet i form av sång dans, koreografi och teater samt koordinator.
Address
Oktavgatan 5
Email
jenny.fromm@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 317 | 434 | 175 | 287 | 163 |
| Staff expenses | — | — | −12 | −108 | −152 |
| EBITDA | −7 | 5 | 103 | 72 | −71 |
| Depreciation & amort. | −8 | −7 | — | — | — |
| EBIT | −15 | −2 | 103 | 72 | −71 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | −15 | −2 | 103 | 72 | −71 |
| Tax | −0 | −0 | −13 | −15 | — |
| Net profit | −15 | −2 | 90 | 57 | −71 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 107 | 86 | 183 | 204 | 94 |
| Equity | 71 | 69 | 159 | 156 | 85 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 35 | 17 | 24 | 48 | 9 |
| Total debt | 35 | 17 | 24 | 48 | 9 |
EBITDA margin
-43.8%
This company
15.8%
Market median
-377% vs market
20202024
Equity ratio
89.9%
This company
38.2%
Market median
+135% vs market
20202024
Return on equity
-84.1%
This company
18.4%
Market median
-557% vs market
20202024
Net profit margin
-43.7%
This company
8.1%
Market median
-640% vs market
20202024
Asset turnover
1.73×
This company
1.12×
Market median
+54% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Endorfin Dopamin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lilli Vinni Charlotta Hedberg | Deputy Board Member | 0 companies |
| Personuppgift Skyddad | Board of Directors | 0 companies |
| Jenny Maria Josefin Fromm Sehlstedt | Chairman | 0 companies |
| Per Olle Hedberg | Deputy Board Member | 0 companies |